Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries Ruby Khatun Khatun25 Sept 2017 9:21 AM ISTBasel: Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current...
NPPA calls for better oversight of private hospitals Ruby Khatun Khatun24 Sept 2017 11:02 AM ISTMUMBAI: Drug pricing authority called for better regulation of the country’s massive private healthcare industry on Friday to ensure government...
Sanofi tests three-in-one antibody to treat or prevent HIV Ruby Khatun Khatun24 Sept 2017 10:37 AM ISTLONDON: A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV,...
FDA declines to approve Johnson and Johnson arthritis drug sirukumab Ruby Khatun Khatun24 Sept 2017 9:57 AM ISTThe U.S. Food and Drug Administration (FDA) has declined to approve Johnson and Johnson’s rheumatoid arthritis drug sirukumab, saying additional...
Merck KGaA, Pfizer gets EU nod for cancer drug Bavencio Ruby Khatun Khatun24 Sept 2017 9:57 AM ISTFRANKFURT: European regulators on Thursday granted market approval for Merck KGaA and Pfizer’s immuno-oncology drug Bavencio to treat a rare and...
Native American tribe moves to dismiss Allergan patent case Ruby Khatun Khatun24 Sept 2017 9:20 AM ISTA Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV...
GSK Pharma to sell land in Maharashtra for Rs 555 crore Ruby Khatun Khatun23 Sept 2017 2:01 PM ISTNew Delhi: GlaxoSmithKline Pharmaceuticals (GSK) said its board has approved the sale of around 60 acres land of the company at Thane in Maharashtra...
Pfizer files suit against Johnson and Johnson over Remicade Ruby Khatun Khatun23 Sept 2017 1:58 PM ISTDrugmaker Pfizer Inc on Wednesday filed a lawsuit against Johnson and Johnson, saying its rival’s contracts with health insurers for blockbuster...
Rs 113 crore spent on maintenance of medical devices: J P Nadda Ruby Khatun Khatun23 Sept 2017 10:42 AM ISTNew Delhi: The government has spent Rs 113 crore in 2016-17 on maintenance of 4,560 medical devices which were not functional in various public...
Orchid Pharma gets EIR from USFDA for its Alathur facility Ruby Khatun Khatun23 Sept 2017 10:19 AM ISTNew Delhi: Orchid Pharma on Thursday said it has received establishment inspection report (EIR) from the US health regulator for its Alathur facility...
FDA clears first duodenoscope with disposable distal cap Ruby Khatun Khatun23 Sept 2017 9:57 AM ISTThe U.S. Food and Drug Administration (FDA) cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for...
Roche receives EU approval for Gazyvaro, European approval for Actemra Ruby Khatun Khatun23 Sept 2017 9:39 AM ISTZURICH: Roche said it has received European approval for its Actemra medication in giant cell arteritis (GCA), the Swiss drugmaker said on Friday.“As...
